HIV曝露新生児におけるネビラピン誘発性スティーブンス・ジョンソン症候群:症例報告
Eimear M O'Connell1, Nthambose Simango1, Bryan J Vonasek1,2
1Department of Pediatrics and Child Health, Queen Elizabeth Central Hospital, Blantyre, Malawi.
Abstract:
A term male infant developed a blistering muco-cutaneous rash in the second week of life following postnatal HIV prophylaxis with nevirapine (NVP). Clinical findings were consistent with Stevens-Johnson syndrome. Following NVP discontinuation, the infant made a full recovery. This first reported neonatal case of nevirapine-induced Stevens-Johnson syndrome highlights the need for vigilance, early recognition, and prompt drug discontinuation to enable resolution and prevent a severe outcome.
さらに関連する動画
10:15Intracerebroventricular Viral Injection of the Neonatal Mouse Brain for Persistent and Widespread Neuronal Transduction
Published on: September 15, 2014
05:53Use of In vivo Imaging to Monitor the Progression of Experimental Mouse Cytomegalovirus Infection in Neonates
Published on: July 6, 2013
関連する概念動画
Teratogenicity
Pharmacokinetics in Pediatric Patients: Drug Excretion
Retroviruses
Subviral Agents
Pharmacokinetics: Drug–Food and Drug–Viral Interactions
Drug toxicity: Idiosyncratic Reactions
